Global Biobanking Market 2021-2025 - Research and Markets

The publisher has been monitoring the biobanking market and it is poised to grow by $ 1.28 bn during 2021-2025, progressing at a CAGR of 8.44% during the forecast period. The report on the biobanking market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing demand for personalized medicine and increase in efficiency through automation will increase demand.

The biobanking market analysis includes the product segment and geographic landscape.

The biobanking market is segmented as below:

By Product

Equipment
Consumables

By Geographical Landscape

North America
Europe
Asia
ROW

This study identifies the reduction in research costs as one of the prime reasons driving the biobanking market growth during the next few years.

The report on biobanking market covers the following areas:

Biobanking market sizing
Biobanking market forecast
Biobanking market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biobanking market vendors that include AMS Biotechnology (Europe) Ltd., ASKION GmbH, Bay Biosciences LLC, Cureline Inc., Firalis SA, GENETICIST Inc., Hamilton Bonaduz AG, ProteoGenex Inc., Thermo Fisher Scientific Inc., and US Biolab Corp. Inc. Also, the biobanking market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary

Market overview

Market Landscape

Market ecosystem
Value chain analysis

Market Sizing

Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product

Market segments
Comparison by Product
Equipment - Market size and forecast 2020-2025
Consumables - Market size and forecast 2020-2025
Market opportunity by Product

Customer landscape

Geographic Landscape

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape

Overview
Landscape disruption

Vendor Analysis

Vendors covered
Market positioning of vendors
AMS Biotechnology (Europe) Ltd.
ASKION GmbH
Bay Biosciences LLC
Cureline Inc.
Firalis SA
GENETICIST Inc.
Hamilton Bonaduz AG
ProteoGenex Inc.
Thermo Fisher Scientific Inc.
US Biolab Corp. Inc.

Appendix

Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

List of Exhibits

Key Finding 1
Key Finding 2
Key Finding 3
Key Finding 5
Key Finding 6
Key Finding 7
Key Finding 8
Parent market
Market characteristics
Offerings of vendors included in the market definition
Market segments
Global - Market size and forecast 2020 - 2025 ($ million)
Global market: Year-over-year growth 2020 - 2025 (%)
Five forces analysis 2020 & 2025
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition - Five forces 2020
Product - Market share 2020-2025 (%)
Comparison by Product
Equipment - Market size and forecast 2020-2025 ($ million)
Equipment - Year-over-year growth 2020-2025 (%)
Consumables - Market size and forecast 2020-2025 ($ million)
Consumables - Year-over-year growth 2020-2025 (%)
Market opportunity by Product
Customer landscape
Market share By Geographical Landscape 2020-2025 (%)
Geographic comparison
North America - Market size and forecast 2020-2025 ($ million)
North America - Year-over-year growth 2020-2025 (%)
Europe - Market size and forecast 2020-2025 ($ million)
Europe - Year-over-year growth 2020-2025 (%)
Asia - Market size and forecast 2020-2025 ($ million)
Asia - Year-over-year growth 2020-2025 (%)
ROW - Market size and forecast 2020-2025 ($ million)
ROW - Year-over-year growth 2020-2025 (%)
Key leading countries
Market opportunity By Geographical Landscape ($ million)
Impact of drivers and challenges
Vendor landscape
Landscape disruption
Industry risks
Vendors covered
Market positioning of vendors
AMS Biotechnology (Europe) Ltd. - Overview
AMS Biotechnology (Europe) Ltd. - Product and service
AMS Biotechnology (Europe) Ltd. - Key offerings
AMS Biotechnology (Europe) Ltd. - Key customers
AMS Biotechnology (Europe) Ltd. - Segment focus
ASKION GmbH - Overview
ASKION GmbH - Product and service
ASKION GmbH - Key offerings
ASKION GmbH - Key customers
ASKION GmbH - Segment focus
Bay Biosciences LLC - Overview
Bay Biosciences LLC - Product and service
Bay Biosciences LLC - Key offerings
Bay Biosciences LLC - Key customers
Bay Biosciences LLC - Segment focus
Cureline Inc. - Overview
Cureline Inc. - Product and service
Cureline Inc. - Key offerings
Cureline Inc. - Key customers
Cureline Inc. - Segment focus
Firalis SA - Overview
Firalis SA - Product and service
Firalis SA - Key offerings
Firalis SA - Key customers
Firalis SA - Segment focus
GENETICIST Inc. - Overview
GENETICIST Inc. - Product and service
GENETICIST Inc. - Key offerings
GENETICIST Inc. - Key customers
GENETICIST Inc. - Segment focus
Hamilton Bonaduz AG - Overview
Hamilton Bonaduz AG - Product and service
Hamilton Bonaduz AG - Key offerings
Hamilton Bonaduz AG - Key customers
Hamilton Bonaduz AG - Segment focus
ProteoGenex Inc. - Overview
ProteoGenex Inc. - Product and service
ProteoGenex Inc. - Key offerings
ProteoGenex Inc. - Key customers
ProteoGenex Inc. - Segment focus
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Key customers
Thermo Fisher Scientific Inc. - Segment focus
US Biolab Corp. Inc. - Overview
US Biolab Corp. Inc. - Product and service
US Biolab Corp. Inc. - Key offerings
US Biolab Corp. Inc. - Key customers
US Biolab Corp. Inc. - Segment focus
Currency conversion rates for US$
Research Methodology
Validation techniques employed for market sizing
Information sources
List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global biobanking market: AMS Biotechnology (Europe) Ltd., ASKION GmbH, Bay Biosciences LLC, Cureline Inc., Firalis SA, GENETICIST Inc., Hamilton Bonaduz AG, ProteoGenex Inc., Thermo Fisher Scientific Inc., and US Biolab Corp. Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is reduction in research costs.`

According to the report, one of the major drivers for this market is the growing demand for personalized medicine.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.